Robust laboratory capacity is critical for the rapid development and distribution of vaccines. It ensures that all stages of vaccine development—from pre-clinical trials to post-market surveillance—are conducted efficiently and accurately. This, in turn, supports public health efforts to prevent and control infectious diseases.
